Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             16 results found
no title author magazine year volume issue page(s) type
1 A lyophilized formulation of RiVax, a recombinant ricin subunit vaccine, retains immunogenicity Smallshaw, Joan E.
2010
28 12 p. 2428-2435
8 p.
article
2 An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination Schmeisser, Falko
2010
28 12 p. 2442-2449
8 p.
article
3 An IL-15 adjuvant enhances the efficacy of a combined DNA vaccine against Brucella by increasing the CD8+ cytotoxic T cell response Hu, Xi-Dan
2010
28 12 p. 2408-2415
8 p.
article
4 A novel canine favored CpG oligodeoxynucleotide capable of enhancing the efficacy of an inactivated aluminum-adjuvanted rabies vaccine of dog use Ren, Jiling
2010
28 12 p. 2458-2464
7 p.
article
5 Capacity of serotype 19A and 15B/C Streptococcus pneumoniae isolates for experimental otitis media: Implications for the conjugate vaccine Laufer, Alison S.
2010
28 12 p. 2450-2457
8 p.
article
6 Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens Brahmakshatriya, Vinayak R.
2010
28 12 p. 2388-2396
9 p.
article
7 Editorial Board 2010
28 12 p. CO2-
1 p.
article
8 Fear, misinformation, and innumerates: How the Wakefield paper, the press, and advocacy groups damaged the public health Poland, Gregory A.
2010
28 12 p. 2361-2362
2 p.
article
9 Huge impact of assumptions on indirect effects on the cost-effectiveness of routine infant vaccination with 7-valent conjugate vaccine (Prevnar®) Rozenbaum, Mark H.
2010
28 12 p. 2367-2369
3 p.
article
10 Immunogenicity and safety of different injection routes and schedules of IC41, a Hepatitis C virus (HCV) peptide vaccine Firbas, Christa
2010
28 12 p. 2397-2407
11 p.
article
11 Immunogenicity of an inactivated Japanese encephalitis vaccine (JE-VAX) in humans over 20 years at USAMRIID: Using PRNT50 as an endpoint for immunogenicity Reisler, Ronald B.
2010
28 12 p. 2436-2441
6 p.
article
12 Influence of serogroup B meningococcal vaccine antigens on growth and survival of the meningococcus in vitro and in ex vivo and in vivo models of infection Seib, Kate L.
2010
28 12 p. 2416-2427
12 p.
article
13 Neutralizing antibody response after intradermal rabies vaccination in hemodialysis patients Tanisaro, Theeraphab
2010
28 12 p. 2385-2387
3 p.
article
14 Staphylococcus aureus vaccine for orthopedic patients: An economic model and analysis Lee, Bruce Y.
2010
28 12 p. 2465-2471
7 p.
article
15 Vaccination against pandemic influenza A/H1N1v in England: A real-time economic evaluation Baguelin, Marc
2010
28 12 p. 2370-2384
15 p.
article
16 Vaccine adjuvants: A priority for vaccine research Harandi, Ali M.
2010
28 12 p. 2363-2366
4 p.
article
                             16 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands